We developed a method, termed Cell and Tissue Display (CTD), for embedding 16 or more different tissue samples in multicompartment agarose blocks. The CTD-generated blocks allow uniform multiplexing of cell lines and small tissue fragments within a single histologic block. The distribution of individual cells within the CTD blocks is improved, likely because the individual agarose compartments are small and uniform. The composition of each CTD block can be customized based on intended use. Some potential uses of CTD histologic blocks include improved sectioning of small tissue fragments, such as needle biopsy specimens or punch biopsies; multiplexing of tissue fragments within a single block; and the generation of control slides for laboratory proficiency testing. (J Histochem Cytochem 64:403 -411, 2016) 
Introduction
A complex need for detailed histologic and molecular analysis in clinical and research biomedicine has resulted in the development of a wide range of assays, such as in situ hybridization, immunofl uorescence, and immunohistochemistry. 1 -3 Reliable preservation of both normal and tumor tissue continues to be integral to the proper use of these assays. One economical and rapid method in the clinical setting is to simply place multiple tissue specimens into a single histologic block. In research investigations, where hypocellular specimens are often a major limitation, investigators frequently turn to adhering cells to slides by culturing cells in vitro or by manually spreading cells on slides. 4 Histologic block-making has undergone iterative improvement over the last several decades. The fi rst hallmark improvement was devised in 1986, when Dr. Hector Battifora developed a "sausage" histologic block method, which entailed the arrangement of multiple approximately 1 mm thick tissue fragments obtained from different specimens in a segment of small intestine. 3 This method marked a signifi cant technological advancement, allowing for multiple tissue specimens to be easily evaluated under identical processing conditions. However, the individual tissue fragments could not be identifi ed with certainty. In 1990, Dr. Battifora modifi ed his original method and termed his new technique the "checkerboard" tissue block. This iteration allowed even distribution and identifi cation of multiple tissue specimens in one block. 5 The next major technological advancement was the development of tissue microarray (TMA) technology by Kononen et al. 6 TMA allowed for the identical confi guration of hundreds of tissue cores within a block. However, technical limitations persisted despite near-universal application of TMA in research settings. Most notably, tissue loss was detected in 10% to 30% of assembled 651065 JHC XX X 10.1369/0022155416651065 Cell and Tissue Display: A New Microscopy Tool Theodosakis et al. research-article 2016 cores, resulting either from loss during cutting or from the transfer of array sections from archival blocks. 7 The most common approach for correcting uneven cell display of tissue fragments on slides was to create multiple cores of an identical case. Similarly, the most common approach used to correct uneven cell displays of cell lines on slides was to massively increase the input, often by increasing the number of cells submitted for the construction of the histologic block. While this may be readily achieved for untreated established cancer cell lines, cells grown in culture are often treated with reagents that cause apoptosis or inhibit cancer cell growth. In those instances, it becomes difficult to procure sufficient numbers of lesional cells to generate blocks.
Other researchers have previously pioneered the incorporation of cell lines in TMAs 8, 9 and agarose blocks 10, 11 or molds 12 to increase yield from paucicellular specimens. Herein, we expand on this knowledge and describe a novel method, Cell and Tissue Display (CTD), which achieves both improved cellular homogeneity of the x-y planes of a z-axis and also permits rapid multiplexing and uniform arrangement of both tissues and cell lines in one block.
Materials and Methods

Cell Culture
Cell lines were provided as a gift by Dr. Ruth Halaban (Yale University, New Haven, CT). 13 Surgical melanoma resections were used to generate the lines. Specimens were collected with patients' informed consent in accordance with the Health Insurance Portability and Accountability Act (HIPAA) under a Human Investigations Committee protocol. All melanoma cell lines (YUVON, YUGASP, YUKOLI, YUHEF, YUROB, YUKSI, YUSIK, YUTIKA, YURIF, WM1346, and YUGEN8) were grown routinely in Opti-MEM® (Invitrogen, Carlsbad, CA) supplemented with 1% penicillin-streptomycin and 10% fetal bovine serum, and maintained in a 37C incubator with 5% CO 2 .
Human Normal Tissue Procurement
Following review, written permission was obtained from the director of autopsy services at Johns Hopkins Hospital to procure fresh normal skin tissue from routine adult autopsies. Apart from designating the tissue of origin for each specimen, no additional identifiers were recorded.
Animal Tissue Preparation
All mice were bred on a C57BL/6 inbred genetic background. All experiments involving animals were reviewed and approved by the Yale Institutional Animal Care and Use Committee. The mice were euthanized according to the Yale University animal protocol. Tissue was harvested and freshly embedded in agarose mold. CTD agarose blocks were fixed in 1% neutral buffer formalin solution for ~1 hr prior to submitting the blocks for routine processing at the Orthopaedic Histology and Histomorphometry Laboratory at the Yale School of Medicine.
Histologic Block Construction
Traditional histologic blocks used as controls were prepared according to previously published protocols. [14] [15] [16] Cytologic blocks were prepared routinely by the Cytology Service at the Yale School of Medicine using standard Cellient™ automated cell block technology (Hologic, Inc., Bedford, MA).
The CTD histologic block procurement method was performed as follows. First, 3 g of standard melting point agarose (UltraPure Agarose, Invitrogen, Inc.) powder was dissolved in 100 ml of 1× phosphate-buffered saline (PBS) solution by heating in a standard microwave for 60 to 90 sec. Molten agarose solution was poured into an inverted pipette container lid from a BioDOT Universal Fit pipette tips container (DOT Scientific, Inc., Burton, MI). Next, either a MicroAmp Optical 96-well reaction plate or a 384-well reaction plate (Life Technologies, Inc., Carlsbad, CA) was placed onto the molten agarose solution. The mixing step, in which cells/tissue are mixed with molten agarose, is critical to perform prior to deposition into the agarose mold to prevent any shrinkage artifact. The preparation was then left at room temperature for 30 min to allow the agarose to solidify. Afterward, the container lid was removed, and the agarose mold was carefully extricated from the plastic lid. The agarose mold was then cut and trimmed to fit into a closed anatomic pathology cassette. Excess agarose mold may be placed in 1 × PBS solution and stored in a refrigerator at 4C for at least 1 month.
Cells were routinely retrieved from cell culture plates, 17 then fixed in 1% buffered formalin solution, optimally at a concentration of 1 × 10 6 cells/ml. Next, 50 ml aliquots were removed and placed into new microcentrifuge tubes. The cells were allowed to settle out of suspension on the benchtop for 30 to 60 min. After the cells have settled, supernatant solvent was carefully removed with a pipette. The remaining cells were resuspended in approximately 50 µl of 1% molten agarose solution and injected into the agarose spots or wells created by the bottoms of the 96-or 348-well reaction plates. The agarose mold was then quickly placed at the corner of an inverted Corning Costar® cell culture plate lid (Sigma-Aldrich, Inc., St. Louis, MO) and spun for 1 to 3 min at 1500 rpm using a Beckman microplate carrier 270-453790-B and G.H. 3.7 Rotor/Centrifuge (Beckman, Inc., Brea, CA) to achieve better cellular homogeneity. For tissue fragment processing, each fragment was placed in a spot or well and covered with molten agarose solution. Cells were enumerated using Countess® Cell Counting Chamber Slides (Life Technologies, Inc., Carlsbad, CA).
The agarose blocks were first allowed to rest on the benchtop for 30 min. They were then placed in 1% buffered formalin solution and taken to the histology laboratory for paraffin embedding. Histoprocessing was performed routinely using a standard vacuum infiltration processor (Shandon Excelsior ES; Thermo Fisher Scientific, Inc., Waltham, MA) at the Orthopaedic Histology and Histomorphometry Laboratory, Yale School of Medicine. We used Paraplast Plus® embedding media (supplier no. 39502004; VWR International, Inc., Radnor, PA) for embedding. The paraffin-embedded CTD histologic blocks were stored routinely at room temperature. At the time of publication of this report (1 year following the original CTD histologic block constructions), we examined the CTD histologic blocks for gross evidence of shrinkage. We detected no shrinkage between specimen and agarose matrix, nor between agarose matrix and surrounding paraffin. Deeper step sections (cut nos. 30, 40, 50, 60, 70, 80, 90, and 100) into CTD histologic blocks were cut routinely, and both unstained sections and hematoxylin and eosin (H&E) stained slides were produced. By cut no. 70, we had cut through two spots or wells so that 10 out of 12 spots/wells were visualized. By cut no. 100, we cut through an additional one spot/well, so that nine out of 12 were visualized.
As CTD entails working with molten agarose, experimenters should use laboratory coats, gloves, silicone insulation sandwiched gloves, and safety goggles. Rarely, molten agarose solution can become superheated and violently boil over immediately after mechanical agitation, such as immediately after lifting the beaker from the microwave.
Antigen Detection
Both immunohistochemistry and immunofluorescence were performed by the Yale Dermatopathology Laboratory. Briefly, antigens were first unmasked in 10 mM sodium citrate buffer (pH 6.0) antigen-retrieval solution using PT Link Module Plus (Dako North America, Inc., Carpinteria, CA). Tissues slides were then processed routinely on Dako Autostainer Plus (Dako North America, Inc.). DAPI (4′,6-diamidino-2-phenylindole, dihydrochloride; product no. D1306) was obtained from Life Technologies, Inc. (Grand Island, NY). Monoclonal mouse anti-human primary antibodies against microphthalmia-associated transcription factor (MITF; product no. M362129-2) at a dilution of 1:100, A1/A3 (product no. M351529-2) at a dilution of 1:50, polyclonal rabbit anti-human primary antibodies against S-100 (product no. Z031129-2) at a dilution of 1:400, and cytokeratin (CK116; product no. Z062201-2) at a dilution of 1:500 were used according to the manufacturer's instructions (Dako North America, Inc.). Secondary anti-mouse antibodies conjugated to horseradish peroxidase (HRP; catalog no. M32207) at a 1:2000 dilution (Thermo Fisher Scientific, Inc.), anti-rabbit antibodies conjugated to fluorescein isothiocyanate (FITC; catalog no. F9887) at a dilution of 1:200 (Sigma-Aldrich Inc.), and anti-rabbit antibodies conjugated to Cy3 (catalog no. C2306) at a dilution of 1:200 (Sigma-Aldrich, Inc.) were used according to the manufacturer's instructions. All antibodies incubations were performed overnight at 4C in the humid chamber.
Image Analysis
Representative digital photomicrographs (400× final magnification) of tissue spots/wells were captured using laboratory microscopes (BX41 microscope with a DP26 camera, Olympus America, Inc., Melville, NY) equipped with imaging software (Diagnostic Instruments, Inc., Sterling Heights, MI). We then used ImageJ analysis software (version 1.49) to measure cellular homogeneity within each photomicrograph. Shapes within each photomicrograph of >100 square pixels with a roundness coefficient between 0.2 and 1 were counted as cells. The contrast threshold was adjusted manually to account for background on each image. Once the cells were defined, a nearest neighbor distance (NND) calculator plugin for ImageJ was used to calculate the NND value for each particle in the field, according to described specifications. 16 
Results
We have developed an alternative approach, termed CTD, to embed cells and/or tissue fragments in small potential spaces, herein termed spots or wells. To begin to create the agarose mold, we started by pouring molten agarose into a plastic receptacle. We then placed empty 96-or 384-well reaction plates over the molten agar to create spots/wells within the agarose (Fig. 1F ). Following solidification of the agarose, cells or tissue fragments were placed in the spots/wells (Fig. 1G) . Agarose molds were cut to fit standard histology cassettes (Fig. 1H) . The specimens were then delivered to the histopathology laboratory for routine embedding and slide preparation.
We compared the performance characteristics of slides created from CTD cell line blocks to three commonly used methods in a series of qualitative (Figs. 2 and 3) and quantitative (Fig. 4) tests. [14] [15] [16] Two of these three methods are traditional histologic techniques used to prepare histologic blocks in the research setting at Johns Hopkins Hospital and the Yale School of Medicine. The third cytologic block method is a standard technique to procure cytologic specimens for routine clinical evaluation. Both the manual inspections and the microscopic evaluations of the CTD sections showed that they can be multiplexed and tiled in consecutive uniform rows and columns, similar to the slides made by TMA technology. Either cells or tissues can be arranged in spots or wells ( Fig. 2D-I) , a feature which represents a technological improvement from the other three common methods of histologic block-making ( Fig. 2A-C ). In addition, mixed cultured cell and tissue fragments can be multiplexed within the same CTD block ( Fig. 2E , 2G-I). Next, we generated another CTD block that contained normal murine tissues procured from routine animal necropsy (Fig. 2D, F) . Within a single histologic block, we arranged 16 unique tissue fragments and achieved full cross-sections of all 16 tissue fragments on a single slide.
Upon microscopic evaluation of the slides made with the CTD method, we noted a marked qualitative improvement in cell homogeneity (Fig. 3A, lower panel) relative to the other three methods (Fig. 3A, upper panel) . Importantly, cells procured by CTD maintained appropriate epitope antigenicity by immunohistochemistry and immunofluorescence (Fig. 3B) . Upon further optimizing the protocol to include an additional centrifugation step prior to agarose-based mold solidification, we observed further enhancement in microscopic homogeneity. To quantify this effect, we applied ImageJ software to representative photomicrographs and evaluated a correction value, NND, which represents the intercellular distances between individual cells. We measured hundreds of NND values within a given field of view. The scores were then reported as relative coefficients of variation (CVs) for NND values (Fig. 4) .
Finally, we determined the cell count and distribution in deeper sections to measure homogeneity through various levels of the z-axis. We focused our analysis of cellularity and distribution on three representative cell lines: a low-cellularity cell line, YURIF; moderate-cellularity cell line, YUKSI; and high-cellularity cell line, YUVON (Fig. 5A) . By applying ImageJ analysis on representative photomicrographs, we determined that the cellularity of all three cell lines remained relatively uniform (Fig. 5B ). On an early cut (cut no. 10), we detected 33 YURIF cells; on an intermediate cut (cut no. 50), we detected 46 YURIF cells; and on a deep cut (cut no. 100), we detected 34 YURIF cells. The number of YUKSI cells was 154, 99, and 113 on cuts 10, 50, and 100, respectively. The number of YUVON cells was 530, 605, and 541 on cuts 10, 50, and 100, respectively. To evaluate the distribution of cells, we determined number of cells and their corresponding NNDs. Both values remained largely unchanged among an early cut (cut no. 10) and later serial cut (cuts no. 50 and 100; Fig. 5C ). YURIF cells retained similar distribution (NND ± CV) on an early cut (149 ± 49), on an intermediate cut (157 ± 43), and on a deep cut (174 ± 52) as well. NND and CV values for YUKSI and YUVON cell lines were 91 ± 31 (cut no. 10), 107 ± 42 (cut no. 50), 103 ± 38 (cut no. 100), and 49 ± 24 (cut no. 10), 43 ± 21 (cut no. 50), 52 ± 22 (cut no. 100), respectively. Taken together, our findings support the hypothesis that microscopic homogeneity in the z-plane of sectioning is reliably achieved with CTD. This feature of our method supports its use in the clinical setting for making histologic blocks using markedly hypocellular specimens, such as buccal swabs. 18
Discussion
The potential applications of CTD for rapidly generating reliable testing controls in the clinical setting are numerous. The need for reliable positive and negative controls in laboratory medicine and clinical pathology necessitates dependable reproducibility from test to test. The marked homogeneity of tissue embedded using CTD from section to section, as well as long-term preservation of antigenicity mark it as ideal for this purpose. We also believe that coupling of CTD to cell-sorting tools such as flow cytometry could be used to construct control blocks containing cell lines both enriched and homogeneous for markers of interest, further improving both reproducibility and utility for quality control. Furthermore, the ability to mix purified cell lines expressing different markers would provide a potential test modality to verify the specificity of new antibodies or staining techniques for clinical use in a controlled manner. Analytic sensitivity may be measured in an analogous fashion by mixing purified cells with variable expressivity of important markers to determine detection thresholds. The biological homogeneity offered by cell lines may also allow better evaluation of the effects of different pre-analytical variables, with controlled manipulation of characteristics such as fixative and length of fixation, yielding improved characterization of false-detection rates. While validation work would have to be done, given that cell lines often express proteins in non-physiologic ranges, comparison with marker-expressing tissue samples may be of use in certain settings.
CTD has the additional advantage of allowing multiple tissue fragments to be tiled directly from the grossing station (in clinical investigations) or the benchtop (in research applications), whereas histologic blocks must be retrieved to create TMAs. Alternatively, if there is a collection of fixed tissue fragments, they can simply be tiled into CTD spots/wells, and the agarose block can be submitted for histopathologic processing. We termed this protocol a prospective, as opposed to retrospective, construction. CTD can also easily be incorporated into a TMA construction by coring the foci of interest.
Using the principles presented herein, any clinical laboratory can construct in-house CTDs that are tailored to their own practice. CTDs can be constructed centrally, then distributed to the practicing clinical laboratories to help improve quality control. Alternatively, the CTD method may prove useful as an alternative platform for initiatives toward synchronization of immunohistochemical staining protocols. 19 With regard to guaranteeing quality from the CTD protocol, we have noted only a handful of minor issues. First, we rarely observed small (approximately 100-200 µm 2 areas, best seen in Fig. 3 , lower panel, center of middle image) cell-free regions, which may be due to artifactual introduction of air bubbles during molten agarose pipetting. This feature indicates that while CTD signifies an improvement in histologic block-making, it is not a perfect method. Second, we rarely observed tissue folding during the microtome-cutting step of the CTD-made blocks. While tissue folding can occur during the routine processing of any histologic block, we plan to adapt an agar-gelatin mix protocol, The y-axis denoted coefficient of variation (CV) for value nearest neighbor distance (NND), which represents the intercellular distances among individual cells within a given field of view. Variegated and comparably higher CV in histologic blocks procured using traditional methods (traditional methods 1 and 2, and the cytologic block method) compared with several iterations of CTD histologic block preparations.
originally developed by Jones and Calabresi, 20 to the next iteration of the CTD methodology.
In addition to CTD, there are two alternative nontraditional methods for creating histologic blocks from paucicellular specimens. The first is the Cellient™ cell block, the method used to create the cytology blocks for comparison in this study. 21 The second method is the rapid formaldehyde fixed-paraffin embedded (FFPE) cell block. 22 In the present report, we observed a qualitative improvement in cellularity in the slides procured with the CTD method compared with the Cellient-prepared cytology blocks. The rapid FFPE method entails wrapping cellular pellets in gauze to improve cellularity, prior to histologic block-making, and was not evaluated in the current study.
The potential for CTD to improve scientific research is also significant. Low-cost assemblies of highly homogeneous arrays of cell lines can be used to rapidly screen for expression of markers of interest without the need for retrieval of frozen stocks or the growth of difficult-to-culture lines. The improved stability of cell lines preserved in this manner may also facilitate sharing of cultured tissue between institutions with fewer concerns over sample viability. In addition, the ability to take multiple cuts from a highly homogeneous block will allow for rapid parallel staining for a large number of markers, without the need to simultaneously process large numbers of separately grown cultures.
Herein, we report the development of a novel protocol for histologic block-making, CTD, which allows for more nuanced and controlled manipulation of cell lines, as well as the multiplexing of cell lines with tissue within the same histologic block. Using CTD allows for better control of the number of cells visible on a given slide, which may allow the construction of histologic blocks from markedly paucicellular specimens, such as primary cells. We demonstrated the utility of CTD by rapidly generating histologic blocks from normal murine tissue, as well as from multiplexed melanoma cell lines. The versatility of this technique lends itself to adaptation to a wide variety of research and clinical needs, which could help improve the utility of histology in mainstream investigative research. the Orthopaedic Histology and Histomorphometry Laboratory, for preparing the tissue slides from the Cell and Tissue Display (CTD) blocks. The authors also thank the Yale Dermatopathology Laboratory for performing immunostaining studies.
